Cyclica is already using AI to discover new medicines based on psychedelics. Here's the presentation the biotech startup used to raise a fresh $17 million.

Cyclica is already using AI to discover new medicines based on psychedelics. Here's the presentation the biotech startup used to raise a fresh $17 million.

Business Insider

Published

· Toronto-based biotech Cyclica on Wednesday closed a $17 million Series B funding round, led by Drive Capital.
· The startup uses machine learning to "flip the problem of drug discovery on its head."
· Cyclica CEO Naheed Kurji provided the pitch deck his team used to close the round exclusively to Business Insider.
·...

Full Article